Higher levels of light-intensity physical activity (LIPA) appears to be associated with a lower risk of all-cause mortality in older adults, regardless of frailty status, according to a study presented at the EPI Lifestyle 2020 Scientific Sessions.
Two US-based prospective studies presented at the recent EPI Scientific Sessions 2020 suggested that replacing animal-based foods with plant-based ones could reduce mortality and cardiovascular disease (CVD) risk.
Increasing olive oil consumption by at least 7 grams per day was associated with a lower risk of cardiovascular disease (CVD), particularly coronary heart disease (CHD), according to a study presented at the EPI Lifestyle 2020 Scientific Sessions.
Patients with type 2 diabetes mellitus (T2DM) who are overweight or obese but have high cardiorespiratory fitness (CRF)* may have a reduced risk of heart failure (HF), according to a study presented at EPI Lifestyle 2020.
Taking oestradiol therapy within 6 years after the start of menopause significantly delayed lipid plaque buildup in arterial walls — a leading cause of atherosclerosis, but such benefit was not seen when starting oestradiol a decade after menopause, reveals a secondary analysis of the ELITE* study presented at the recent EPI Lifestyle 2020 Scientific Sessions.
Having sufficient and healthy sleep, in addition to adopting healthy lifestyle based on the AHA* Life’s Simple 7 (LS7) guidelines, can reduce the risk of cardiovascular diseases (CVD), according to the longitudinal MESA** Sleep Study presented at EPI Lifestyle 2020 Scientific Sessions.
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS Doctor - Malaysia digital copy today!
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.